Isomerase was founded over 10 years ago, following the acquisition of a range of proprietary technologies around enzyme engineering, natural products bioengineering and strain development. Since then, we have expanded our technology capabilities, expertise and number of locations to accommodate and support exciting developments in the use of microbes to support health and sustainability. We offer the breadth of technologies to support Partners from conception to market, unified by our inspiration by and focus on leveraging the opportunities enabled by working with microbes. Our technical capabilities can broadly be split across three disciplines:
- Enzyme discovery and engineering
- Analogue generation
- Strain bioengineering
- Pathway engineering
- Proprietary strains
- Pichia Engineering
How can Isomerase’s technologies help your project?
Our combination of non-proprietary and proprietary technologies gives our partners access to state-of-the-art methods in bioengineering, strain development, bioinformatics, bioprocess and chemistry.
Isomerase has teams of expert biologists and chemists who can direct your project through every stage from initial concept, bioinformatics, engineering design and strain development, process optimisation and scale-up.
Contact us to discuss how our innovative technologies, such as in synthetic biology, process development, chemistry and bioinformatics can support your project.